Pricing Log in Create free account

TuHURA Biosciences, Inc. (HURA) vs Neumora Therapeutics, Inc. (NMRA)

TuHURA Biosciences, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. is the larger, with a market value of $102.6M against $91.5M — 1.1× the size. Across the 10 metrics below, TuHURA Biosciences, Inc. leads on 7 and Neumora Therapeutics, Inc. on 3.

Valuation

Metric HURA NMRA Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 5.69 2.08 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (33.33%) (246.00%) (34.89%)
Free cash flow yield (28.89%) (194.76%) (24.52%)

Profitability

Metric HURA NMRA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.84%) (187.11%) (50.12%)
Return on assets (92.31%) (121.89%) (45.60%)
Return on invested capital (74.20%) 0.00% 0.00%

Growth

Metric HURA NMRA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 47.93% 5.23% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric HURA NMRA Biotechnology median
Debt to equity 0.47 1.19 0.00
Current ratio 0.18 4.50 4.89
Net debt to EBITDA 0.12 0.53 1.01

Dividend

Metric HURA NMRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HURA NMRA Biotechnology median
Market cap 102.60m 91.51m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack